4
Changes in Ownership
ARROWHEAD PHARMACEUTICALS, INC. Filed Acc 0001209191-19-001472
Chief Operating Officer sold 20,000 shares at $11.98 ($239,600)
- Chief Operating Officer acquired 210,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| GIVEN BRUCE D Chief Operating Officer | 2019-01-01 | Grant or award | +210,000 | 1,118,356 | D: show line 1 in the form | ||
| GIVEN BRUCE D Chief Operating Officer | 2019-01-02 | Sale | −20,000 | $11.98 | $239,600 | 1,098,356 | D: show line 2 in the form |
| Open-market sales · 20,000 sh · avg $11.98 · $239,600 | |||||||
Loading xslF345X03/doc4.xml…